Tech Company Financing Transactions

Tansna Therapeutics Funding Round

On 9/30/2013, Tansna Therapeutics raised $100 thousand in funding from BioGenerator.

Transaction Overview

Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
36 Denbigh Dr. 303
Iowa City, IA 52246
USA
Website
Email Address
Not Recorded
Overview
Tansna Therapeutics, Inc. develops and offers oral drugs to treat epilepsy. The company was founded in 2010.
Profile
Tansna Therapeutics LinkedIn Company Profile
Social Media
Tansna Therapeutics Company Twitter Account
Company News
Tansna Therapeutics News
Facebook
Tansna Therapeutics on Facebook
YouTube
Tansna Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Karr
  Robert Karr LinkedIn Profile  Robert Karr Twitter Account  Robert Karr News  Robert Karr on Facebook
Chief Financial Officer
Kathleen Beckmann
  Kathleen Beckmann LinkedIn Profile  Kathleen Beckmann Twitter Account  Kathleen Beckmann News  Kathleen Beckmann on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2013: Food Genius venture capital transaction
Next: 9/30/2013: Vsnap venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary